Protocol Review (CRC)
Protocol Review (CRC)
批准号:
8559786
负责人:
Charles M. Rudin
金额:
$8.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
约翰霍普金斯大学西德尼·基梅尔综合癌症中心(SKCCC)的方案审查和监测系统临床研究审查委员会(PRMS-CRC)负责审查该中心临床研究的科学价值、优先事项和进展。在癌症中心开放方案之前,需要得到委员会的批准。委员会还有权关闭没有显示出足够的科学进步的议定书。2010年,委员会平均每周审查三份新的研究报告,一份重新提交的关于《减贫战略--儿童权利公约》建议修改的研究报告,以及两份关于年度进展和业绩的研究报告。CRC是我们的议定书审查和监测系统(PRMS)。
英文摘要
The Protocol Review and Monitoring System Clinical Research Review Committee (PRMS-CRC) of the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins is responsible for reviewing the scientific merit, priorities, and progress of the clinical research of the Center. Committee approval is required prior to opening a protocol in the Cancer Center. The Committee also has the authority to close protocols that do not demonstrate adequate scientific progress. On average, in 2010 each week the Committee reviewed three new studies, one resubmitted study with PRMS-CRC recommended changes, and two studies for annual progress and performance. The CRC is our Protocol Review and Monitoring System (PRMS).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel therapeutic development for small cell lung cancer
-
批准号:10296831
-
项目类别:
-
资助金额:$106.2万
-
财政年份:2021
-
负责人:Charles M. Rudin
-
依托单位:
Drivers of histologic transformation in EGFR-mutant lung cancer
-
批准号:10689103
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2021
-
负责人:Charles M. Rudin
-
依托单位:
Novel therapeutic development for small cell lung cancer
-
批准号:10684871
-
项目类别:
-
资助金额:$104.08万
-
财政年份:2021
-
负责人:Charles M. Rudin
-
依托单位:
Coordinating center for the NCI small cell lung cancer research consortium
-
批准号:10091407
-
项目类别:
-
资助金额:$107.12万
-
财政年份:2017
-
负责人:Charles M. Rudin
-
依托单位:
Determinants of acquired resistance in small cell lung cancer
-
批准号:9896775
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2016
-
负责人:Charles M. Rudin
-
依托单位:
Determinants of acquired resistance in small cell lung cancer
-
批准号:9106963
-
项目类别:
-
资助金额:$61.56万
-
财政年份:2016
-
负责人:Charles M. Rudin
-
依托单位:
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
-
批准号:8967020
-
项目类别:
-
资助金额:$57.08万
-
财政年份:2015
-
负责人:Charles M. Rudin
-
依托单位:
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
-
批准号:9115563
-
项目类别:
-
资助金额:$57.08万
-
财政年份:2015
-
负责人:Charles M. Rudin
-
依托单位:
Protocol Review (CRC)
-
批准号:8559690
-
项目类别:
-
资助金额:$8.66万
-
财政年份:2012
-
负责人:Charles M. Rudin
-
依托单位:
Phase I/II Study of MS-275 and 5-Azacytidine in Patients with Advanced Non-Small
-
批准号:7422335
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:Charles M. Rudin
-
依托单位:
A pharmacogenetic and pharmacodynamic study of erlotinib
-
批准号:6741436
-
项目类别:
-
资助金额:$18.99万
-
财政年份:2003
-
负责人:Charles M. Rudin
-
依托单位:
CLINICAL RESEARCH OFFICE
-
批准号:8559535
-
项目类别:
-
资助金额:$61.36万
-
财政年份:1997
-
负责人:Charles M. Rudin
-
依托单位:
Protocol Review (CRC)
-
批准号:8661023
-
项目类别:
-
资助金额:$8.31万
-
财政年份:--
-
负责人:Charles M. Rudin
-
依托单位:
CLINICAL RESEARCH OFFICE
-
批准号:9061613
-
项目类别:
-
资助金额:$61.36万
-
财政年份:--
-
负责人:Charles M. Rudin
-
依托单位:
CLINICAL RESEARCH OFFICE
-
批准号:8559722
-
项目类别:
-
资助金额:$57.37万
-
财政年份:--
-
负责人:Charles M. Rudin
-
依托单位:
Protocol Review (CRC)
-
批准号:8858553
-
项目类别:
-
资助金额:$8.66万
-
财政年份:--
-
负责人:Charles M. Rudin
-
依托单位:
海外基金